EGFR and non-small cell lung carcinoma: Furthermore, AlmoR1 exhibits broad resistance to multiple third‐generation EGFR‐TKIs, making it an ideal model for studying resistance mechanisms and screening new drugs targeting NSCLC brain metastases.